300 related articles for article (PubMed ID: 23692637)
1. A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke.
Hess DC; Sila CA; Furlan AJ; Wechsler LR; Switzer JA; Mays RW
Int J Stroke; 2014 Apr; 9(3):381-6. PubMed ID: 23692637
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial.
Houkin K; Osanai T; Uchiyama S; Minematsu K; Taguchi A; Maruichi K; Niiya Y; Asaoka K; Kuga Y; Takizawa K; Haraguchi K; Yoshimura S; Kimura K; Tokunaga K; Aoyama A; Ikawa F; Inenaga C; Abe T; Tominaga A; Takahashi S; Kudo K; Fujimura M; Sugiyama T; Ito M; Kawabori M; Hess DC; Savitz SI; Hirano T;
JAMA Neurol; 2024 Feb; 81(2):154-162. PubMed ID: 38227308
[TBL] [Abstract][Full Text] [Related]
3. Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study.
Penn MS; Ellis S; Gandhi S; Greenbaum A; Hodes Z; Mendelsohn FO; Strasser D; Ting AE; Sherman W
Circ Res; 2012 Jan; 110(2):304-11. PubMed ID: 22052917
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial.
Moniche F; Escudero I; Zapata-Arriaza E; Usero-Ruiz M; Prieto-León M; de la Torre J; Gamero MA; Tamayo JA; Ochoa-Sepúlveda JJ; Maestre J; Carmona M; Piñero P; Calderón-Cabrera C; Jimenez MD; Gonzalez A; Montaner J
Int J Stroke; 2015 Oct; 10(7):1149-52. PubMed ID: 26044701
[TBL] [Abstract][Full Text] [Related]
5. Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: Rationale and design.
Osanai T; Houkin K; Uchiyama S; Minematsu K; Taguchi A; Terasaka S
Int J Stroke; 2018 Jun; 13(4):444-448. PubMed ID: 29134924
[TBL] [Abstract][Full Text] [Related]
6. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF
J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
Hess DC; Wechsler LR; Clark WM; Savitz SI; Ford GA; Chiu D; Yavagal DR; Uchino K; Liebeskind DS; Auchus AP; Sen S; Sila CA; Vest JD; Mays RW
Lancet Neurol; 2017 May; 16(5):360-368. PubMed ID: 28320635
[TBL] [Abstract][Full Text] [Related]
8. The Desmoteplase in Acute Ischemic Stroke (DIAS) clinical trial program.
von Kummer R; Albers GW; Mori E;
Int J Stroke; 2012 Oct; 7(7):589-96. PubMed ID: 22989394
[TBL] [Abstract][Full Text] [Related]
9. CHIMES-I: sub-group analyzes of the effects of NeuroAiD according to baseline brain imaging characteristics among patients randomized in the CHIMES study.
Navarro JC; Chen CL; Lagamayo PD; Geslani MB; Eow GB; Poungvarin N; de Silva A; Wong LK; Venketasubramanian N;
Int J Stroke; 2013 Aug; 8(6):491-4. PubMed ID: 23506216
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
[TBL] [Abstract][Full Text] [Related]
11. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
[TBL] [Abstract][Full Text] [Related]
12. Human choriogonadotropin and epoetin alfa in acute ischemic stroke patients (REGENESIS-LED trial).
Cramer SC; Hill MD;
Int J Stroke; 2014 Apr; 9(3):321-7. PubMed ID: 24588854
[TBL] [Abstract][Full Text] [Related]
13. The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in acute ischemic stroke: a randomized, double-blind, placebo-controlled, multinational pivotal phase III study.
Rosenberg G; Bornstein N; Diener HC; Gorelick PB; Shuaib A; Lees K;
Int J Stroke; 2011 Aug; 6(4):362-7. PubMed ID: 21645269
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial.
Deng L; Peng Q; Wang H; Pan J; Zhou Y; Pan K; Li J; Wu Y; Wang Y
Transl Stroke Res; 2019 Apr; 10(2):170-177. PubMed ID: 29796934
[TBL] [Abstract][Full Text] [Related]
15. NeuroThera® Efficacy and Safety Trial-3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® Laser System for the treatment of acute ischemic stroke within 24 h of stroke onset.
Zivin JA; Sehra R; Shoshoo A; Albers GW; Bornstein NM; Dahlof B; Kasner SE; Howard G; Shuaib A; Streeter J; Richieri SP; Hacke W;
Int J Stroke; 2014 Oct; 9(7):950-5. PubMed ID: 23013107
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind, phase I/II study of intravenous allogeneic mesenchymal stromal cells in acute myocardial infarction.
Chullikana A; Majumdar AS; Gottipamula S; Krishnamurthy S; Kumar AS; Prakash VS; Gupta PK
Cytotherapy; 2015 Mar; 17(3):250-61. PubMed ID: 25484310
[TBL] [Abstract][Full Text] [Related]
17. The URICO-ICTUS study, a phase 3 study of combined treatment with uric acid and rtPA administered intravenously in acute ischaemic stroke patients within the first 4.5 h of onset of symptoms.
Amaro S; Cánovas D; Castellanos M; Gállego J; Martí-Fèbregas J; Segura T; Chamorro A
Int J Stroke; 2010 Aug; 5(4):325-8. PubMed ID: 20636718
[TBL] [Abstract][Full Text] [Related]
18. Stem cell therapy: a clinical trial of stroke.
Bhasin A; Srivastava MV; Mohanty S; Bhatia R; Kumaran SS; Bose S
Clin Neurol Neurosurg; 2013 Jul; 115(7):1003-8. PubMed ID: 23183251
[TBL] [Abstract][Full Text] [Related]
19. A two-year follow-up study of cotransplantation with neural stem/progenitor cells and mesenchymal stromal cells in ischemic stroke patients.
Qiao LY; Huang FJ; Zhao M; Xie JH; Shi J; Wang J; Lin XZ; Zuo H; Wang YL; Geng TC
Cell Transplant; 2014; 23 Suppl 1():S65-72. PubMed ID: 25333752
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy.
Trachtenberg B; Velazquez DL; Williams AR; McNiece I; Fishman J; Nguyen K; Rouy D; Altman P; Schwarz R; Mendizabal A; Oskouei B; Byrnes J; Soto V; Tracy M; Zambrano JP; Heldman AW; Hare JM
Am Heart J; 2011 Mar; 161(3):487-93. PubMed ID: 21392602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]